Cycle design:
Cycles are assembled by, first, determining the end response characteristics desired, and assembling components whose AAS characteristics interlock together to produce that end response with a minimum of overlap, over the cycle timespan desired. Consider this cycle: Nandrolone phenylpropionate(EOD), tren(EOD), Winstrol depot((ED), optional Anavar(ED). I've remarked, elsewhere, on the desireability of pairing tren with Winstrol. We require the use of a pure androgen for EVERY cycle, to insure strength, onging muscle definition, density, and post cycle androgenicity, so Anavar is our choice for this cycle. Here, Tren is our primary androgen, and nandrolone our primary anabolic. All of these agents are selected for their lack of water retention. All are either short acting or esterless, so that meets our requirements for site injection. And, yes, we do site inject it all. We begin by frontloading the estered injectables, up to three days before cycle day zero, and add the orals and esterless injectables at cycle day minus one. On cycle day zero, the AAS is already active, with blood levels increasing. We end the injectables and orals, suitably in advance of the end of the cycle, so that, on cycle day 15, the AAS is non-inhibitory, and HTPA recovery begins immediately. Add on 14 days further system recovery, and then a cycle can begin anew.Seven weeks, total. Over a year, this might be acccomplished seven times. When HCG, and an anti-e at suitable dosage, are added to the Clomid, the HTPA may be recovered in only 2 weeks. This shortens the next cycle availability point by one week.